AR038245A1 - Formulacion para vaca seca - Google Patents

Formulacion para vaca seca

Info

Publication number
AR038245A1
AR038245A1 ARP030100285A ARP030100285A AR038245A1 AR 038245 A1 AR038245 A1 AR 038245A1 AR P030100285 A ARP030100285 A AR P030100285A AR P030100285 A ARP030100285 A AR P030100285A AR 038245 A1 AR038245 A1 AR 038245A1
Authority
AR
Argentina
Prior art keywords
formulation
dry cow
breast
dry
cefquinoma
Prior art date
Application number
ARP030100285A
Other languages
English (en)
Inventor
Alan Banting
Sylvie Banting
Michel Duval
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of AR038245A1 publication Critical patent/AR038245A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición veterinaria para la administración intramamaria para el tratamiento y prevención de trastornos mamarios durante el período seco, que comprende cefquinoma en una base de aceite/dióxido de silicio coloidal.
ARP030100285A 2002-02-01 2003-01-31 Formulacion para vaca seca AR038245A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02075464 2002-02-01

Publications (1)

Publication Number Publication Date
AR038245A1 true AR038245A1 (es) 2005-01-05

Family

ID=27635869

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100285A AR038245A1 (es) 2002-02-01 2003-01-31 Formulacion para vaca seca

Country Status (2)

Country Link
AR (1) AR038245A1 (es)
WO (1) WO2003063877A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2501395C (en) * 2002-10-25 2011-05-24 Akzo Nobel Nv Prolonged release pharmaceutical composition
US6911441B2 (en) 2002-12-16 2005-06-28 Akzo Nobel N.V. Prolonged release pharmaceutical composition
WO2008025773A1 (en) * 2006-08-30 2008-03-06 Intervet International B.V. Pharmaceutical compositions comprising cefquinome
DE102007055341A1 (de) 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
AR077320A1 (es) * 2009-07-20 2011-08-17 Intervet Int Bv Metodo para la preparacion de particulas de cefquinoma y formulaciones farmaceuticas que las comprenden.
WO2012095438A1 (en) 2011-01-12 2012-07-19 Intervet International B.V. Particles and suspensions of cephalosporin antibiotics
BR112013016851B1 (pt) * 2011-01-12 2021-08-31 Intervet International B.V Método para preparar uma composição farmacêutica que compreende partículas de uma droga
RU2476206C1 (ru) * 2011-11-22 2013-02-27 Виктор Львович Лимонов Фармацевтическая композиция для приготовления инфузионных растворов антимикробных препаратов, способ ее получения (варианты)
ES2740958T3 (es) * 2012-02-27 2020-02-07 Bayer New Zealand Ltd Composiciones de liberación controlada y sus procedimientos de uso
AU2015261543C1 (en) * 2012-02-27 2022-10-13 Elanco New Zealand Controlled release compositions and their methods of use
CN104546703B (zh) * 2013-12-10 2017-06-23 中国农业科学院饲料研究所 一种奶牛泌乳期用硫酸头孢喹肟乳房注入剂及其制备方法
CN104873462B (zh) * 2014-11-18 2017-04-05 中国农业科学院饲料研究所 一种奶牛干乳期用硫酸头孢喹肟乳房注入剂及其制备方法
CN104840420B (zh) * 2014-11-18 2017-04-05 中国农业科学院饲料研究所 一种用于奶牛泌乳期子宫炎的硫酸头孢喹肟子宫注入剂及其制备方法
CN105796491A (zh) * 2016-03-30 2016-07-27 佛山市南海东方澳龙制药有限公司 一种组合物及其应用、含有该组合物的制剂
CN106344509B (zh) * 2016-10-26 2020-01-03 成都乾坤动物药业股份有限公司 一种硫酸头孢喹肟油混悬剂及其制备方法
DE102018122533A1 (de) * 2018-09-14 2020-03-19 Institut Dr. Rilling Healthcare Gmbh Brenn- und essbare Zusammensetzung aus mittelkettigen Trigliceriden und Kieselsäure
CN114869850B (zh) * 2022-06-20 2023-04-28 山东晟阳生物工程有限公司 硫酸头孢喹肟注射液

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3252859A (en) * 1962-10-24 1966-05-24 Masti Kure Company Inc Colloidal silica-oil composition and method of using same
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
GB8531609D0 (en) * 1985-12-23 1986-02-05 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
WO2003063877A1 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
AR038245A1 (es) Formulacion para vaca seca
DE602004029369D1 (de) Halbfeste mukoadhäsive formulierungen
TR200103575T2 (tr) Sülfonamid ve sülfamid ikameli/katkılı imidazokinolinler
DK1689724T3 (da) Quinazolinonforbindelser som anticancermidler
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
PT1347971E (pt) Inibidores tiazolilicos de tirosina-cinases da familia tec
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
MXPA05010476A (es) Composiciones de inhibidores selectivos de ciclooxigenasa-2 y agonistas de 5-hidroxitripamina1b/1d para el tratamiento y prevencion de migrana.
DE60327103D1 (de) Darreichungsformen enthaltend einen protonpumphemmer, einen nsaid und einen puffer
HN2000000166A (es) Composicion de ovulos intravaginales de clindamicina
AR028296A1 (es) Metodos sinergisticos y composiciones para el tratamiento del cancer
CY1110664T1 (el) Ενδορινικες συνθεσετς
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
IL172423A0 (en) Novel formulations for opioid -based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives
PT1237551E (pt) Formulacoes farmaceuticas contendo zolmitriptano
TR200402628T4 (tr) Androjenetik ve yaygın alopezinin tedavisinde melatonin maddesinin kullanımı
NO20052557D0 (no) Morfolinderivater for bruk som dopamin-agonister i behandling av blant annet seksuell dysfunksjon.
HK1086548A1 (en) Deuterated catecholamine derivatives and medicaments comprising said compounds
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
EP1503748A4 (en) DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY
UA92592C2 (en) Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an anti-mitotic cytotoxic agent such as taxane for the treatment of cancer
PA8558501A1 (es) 1,3-diarilprop-2-en1-onas, composiciones que las contienen y su utilizacion
NO20045437L (no) Medikamenter for behandling av akutte dysfunksjoner i portavenesirkulasjon og hepatisk sirkulasjon
MD2228G2 (ro) Utilizarea derivaţiilor izotiouronici în tratamentul şi profilaxia atoniei intestinale
SE0300830D0 (sv) New formulations and use thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal